From the databaseWhat the row says.
Every entry follows the same shape: what is happening, the mechanism, and the recommendation.
Scope
Supplement × Prescription
Last verified
June 4, 2026
CautionEmerging evidence
What is happening. Berberine may lower glucose, while beta blockers can mask adrenergic warning signs of hypoglycemia such as tachycardia.
Mechanism. Potential glucose lowering plus beta-blocker masking of sympathetic symptoms can delay recognition of hypoglycemia.
Recommendation. Use glucose monitoring if diabetic or taking glucose-lowering drugs; do not rely only on palpitations as a hypoglycemia warning sign.
Stack Score
How it moves the number.
Effect on the composite score
If both Berberine and Labetalol are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.
SourcesSources, by evidence tier.
Every claim on this page is cited. PMIDs link straight to PubMed.
Reference material
1- 1DailyMed. Labetalol US prescribing information. 2026.Needs sourceNo link